Do Not Open the Door
By Marcy Darnovsky,
Southwestern Medical Perspectives
| 12. 04. 2019
Should CRISPR be used to alter the genes and traits of future children and generations? Dozens of nations have considered this prospect and decided that manipulating the human germline should be legally off limits. The U.S. and China have not.
Some gene-editing enthusiasts now want to reopen the question. The answer will affect us all and shape the future. Yet despite the stakes being so high, many discussions of heritable genome editing are distorted by dubious assumptions. The claim that editing human embryos is needed to save babies from inherited disease and could “reduce human suffering in profound and meaningful ways,” for example, is misleading for several reasons.
First is the substantial risk of introducing rather than preventing harm. Editing an embryo’s genes can go wrong in multiple ways, including off-target edits, on-target but inaccurate edits, and a condition called mosaicism that produces a mix of altered and unaltered cells in an embryo – and in the resulting child. No one knows what the health effects of these unintended changes might be, for that child or for future generations.
Second: Safe options...
Related Articles
By Anumita Kaur [cites CGS’ Katie Hasson], The Washington Post | 03.25.2025
Genetic information company 23andMe has said that it is headed to bankruptcy court, raising questions for what happens to the DNA shared by millions of people with the company via saliva test kits.
Sunday’s announcement clears the way for a new...
By Peter Wehling, Tino Plümecke, and Isabelle Bartram
| 03.26.2025
This article was originally published as “Soziogenomik und polygene Scores” in issue 272 (February 2025) of the German-language journal Gen-ethischer Informationsdienst (GID); translated by the authors.
In mid-November 2024, the British organization Hope not Hate published its investigative research ‘Inside the Eugenics Revival’. In addition to documentating an active international “race research” network, the investigation also brought to light the existence of a US start-up that offers eugenic embryo selection. Heliospect Genomics aims to enable wealthy couples to...
By Frank Landymore, Futurism | 03.18.2025
You can only throw so much money at a problem.
This, more or less, is the line being taken by AI researchers in a recent survey. Asked whether "scaling up" current AI approaches could lead to achieving artificial general...
By Craig S. Smith, Forbes | 03.08.2025
One recent evening in Shenzhen, a group of software engineers gathered in a dimly lit co-working space, furiously typing as they monitored the performance of a new AI system. The air was electric, thick with the hum of servers and...